Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglidase-M 500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

East West Pharma

Salt Composition

Metformin (500mg) + Voglibose (0.2mg)

Overview Voglidase-M 500mg/0.2mg Tablet

Diabeticaid-M 500mg/0.2mg tablets are classified as anti-diabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabeticaid-M 500mg/0.2mg tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of complications including renal impairment, vision loss, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive treatment plan incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Possible side effects include nausea, altered taste, decreased appetite, gas, abdominal discomfort, diarrhea, and skin rashes; these are typically transient and self-limiting. Persistent or concerning side effects warrant medical consultation. Your physician can offer strategies for managing or treating bothersome side effects. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal dysfunction. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function may be recommended by your doctor.

Uses of Voglidase-M 500mg/0.2mg Tablet

Managing Type 2 diabetes

Major Benefits of Voglidase-M 500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Voglidase-M 500mg/0.2mg tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.

Common Side effects of Voglidase-M 500mg/0.2mg Tablet:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use Voglidase-M 500mg/0.2mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 500mg/0.2mg Voglidase-M tablet whole; avoid chewing, crushing, or fracturing. Consume this medication with a meal.

How Voglidase-M 500mg/0.2mg Tablet works:

Each Voglidase-M 500mg/0.2mg tablet contains a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Voglidase-M 500mg/0.2mg Tablet poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Voglidase-M 500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Voglidase-M 500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is generally unaffected by Voglidase-M 500mg/0.2mg Tablets. Nevertheless, patients using this medication concurrently with other blood sugar-lowering drugs, including sulfonylureas, insulin, and repaglinide, should be aware of the potential for low blood sugar.

KidneyKidneyCAUTION

Exercise caution when administering Voglidase-M 500mg/0.2mg tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician. Voglidase-M 500mg/0.2mg tablets are contraindicated in patients exhibiting severe renal insufficiency. Routine monitoring of renal function is recommended during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Voglidase-M 500mg/0.2mg Tablet use in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Voglidase-M 500mg/0.2mg Tablet :

Should you forget a Voglidase-M 500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglidase-M 500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management
Voglidase-M 500mg/0.2mg T...
74
MRP 90
17% off